Researchers at the University of Texas (UT) Southwestern Medical Center have developed a technique that corrects a mutation leading to Duchenne muscular dystrophy (DMD). The technique, called CRISPR/Cas9-mediated genome editing, removes the mutation entirely in mice, and could have far-reaching consequences in the treatment of muscular dystrophy in people... Continue Reading New gene editing method corrects muscular dystrophy in mice

Section: Medical

Tags: DNA, gene therapy, Genome, Muscular Dystrophy, University of Texas

Related Articles:




-->